CytoDyn’s PRO 140 Phase 2b HIV Monotherapy Trial Findings to be Presented at ASM Microbe 2016 Conference on June 20

Jun 17, 2016 6:30am EDT

CytoDyn to Present at LD Micro Invitational Conference on June 7

Jun 02, 2016 6:30am EDT

Clinical Abstract from CytoDyn’s PRO 140 Phase 2b HIV Monotherapy Trial Now Available on ASM Microbe 2016 Conference Website

May 16, 2016 4:33pm EDT

CytoDyn Announces Investment Community Conference Call for May 11, 2016

May 09, 2016 2:28pm EDT

CytoDyn’s Compassionate Use Protocol Receives FDA Clearance to Proceed

May 03, 2016 6:00am EDT

CytoDyn Reports Complete Viral Load Suppression in HIV-Infected Patients for Up to 20 Months in PRO 140 Monotherapy Extension Study

Apr 18, 2016 6:00am EDT

CytoDyn Files a Compassionate Use Protocol With FDA

Apr 14, 2016 9:00am EDT

CytoDyn to Present PRO 140 Monotherapy Clinical Results at ASM Microbe 2016 Conference

Mar 28, 2016 6:30am EDT

CytoDyn Announces Investment Community Conference Call for March 24, 2016

Mar 22, 2016 4:01pm EDT

CytoDyn Initiates Phase 3 Monotherapy Trial for HIV Patients

Feb 23, 2016 6:30am EST